Assessment the Cancer Risk of Indeterminate Thyroid Nodules Through Integration of Clinical, Ultrasonographic and Multiomic Features (THYOMICS)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05428371 |
Recruitment Status :
Not yet recruiting
First Posted : June 23, 2022
Last Update Posted : June 23, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Thyroid Nodule Thyroid Cancer | Diagnostic Test: Multiomic analyses of blood and surgical specimens |
Study Type : | Observational |
Estimated Enrollment : | 256 participants |
Observational Model: | Case-Control |
Time Perspective: | Prospective |
Official Title: | A Novel, Multimodal, Machine-learning Grounded Approach to Assess the Oncological Risk of Indeterminate Thyroid Nodules |
Estimated Study Start Date : | January 1, 2023 |
Estimated Primary Completion Date : | May 31, 2027 |
Estimated Study Completion Date : | December 31, 2027 |
Group/Cohort | Intervention/treatment |
---|---|
Thyroid carcinoma
Patients with indeterminate thyroid nodule and pathological diagnosis of thyroid carcinoma
|
Diagnostic Test: Multiomic analyses of blood and surgical specimens
The following items will be evaluated:
|
Follicular adenoma
Patients with indeterminate thyroid nodule and pathological diagnosis of follicular adenoma
|
Diagnostic Test: Multiomic analyses of blood and surgical specimens
The following items will be evaluated:
|
- Identification of biomarkers of thyroid carcinoma [ Time Frame: 50 months ]Identification of alterations in cfDNA length and integrity, presence of SNPs in cfDNA, alterations of serum proteome predictive of thyroid carcinoma
- Elaboration of diagnostic algorithm [ Time Frame: 60 months ]Elanoration of diagnostic algorithm predictive of thyroid carcinoma through integration of clinical, ultrasonographic and multiomic variables able to predict che condition of thyroid cancer in patients with indeterminate thryoid nodules
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients with indeterminate thyroid nodules (Class III and Class IV according to Bethesda Classification of thyroid nodules)
Exclusion Criteria:
- Patients with concomitant thyroid nodules of Bethesda Class V or Class VI
- Patients with preoperative diagnosis of lymph node metastases of central or lateral neck compartment
- Patients with distant metastases
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05428371
Italy | |
AOU Cagliari | |
Cagliari, CA, Italy, 09100 |
Responsible Party: | Fabio Medas, Associate Professor, University of Cagliari |
ClinicalTrials.gov Identifier: | NCT05428371 |
Other Study ID Numbers: |
THYOMICS |
First Posted: | June 23, 2022 Key Record Dates |
Last Update Posted: | June 23, 2022 |
Last Verified: | June 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Plan Description: | Individual participant data will be available under reasonable request |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Thyroid carcinoma Indeterminate thyroid nodule Genomics Proteomics Metabolomics |
Thyroid Nodule Thyroid Diseases Endocrine System Diseases Thyroid Neoplasms |
Endocrine Gland Neoplasms Neoplasms by Site Neoplasms Head and Neck Neoplasms |